Major investment for respiratory diseases completed Major investment for respiratory diseases completed 105 million euros invested into expansion of production facilities in Ingelheim and Dortmund
We support non-linear career paths. We support non-linear career paths. Emmanuelle Clerisme-Beaty talks about making breakthroughs in the rare disease space.“I’m here to let patients know that they're not alone”
Aservo EquiHaler wins Red Dot 2020 for design quality Aservo EquiHaler wins Red Dot 2020 for design quality Aservo EquiHaler wins a prestigious Red Dot Award 2020 for outstanding design quality
Netherton Syndrome Netherton Syndrome Information on Netherton Syndrome, a severe, ultra-rare multisystem disorder which has a life-altering impact across a person’s life.
Reimagining digital healthcare worldwide Reimagining digital healthcare worldwide How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
discontinuation-bi-1467335-diabetic-retinopathy discontinuation-bi-1467335-diabetic-retinopathy The discontinuation of the development of BI 1467335 in diabetic retinopathy has been announced
1885-1948: Innovative beginnings 1885-1948: Innovative beginnings The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products
1990-2023: Value through Innovation 1990-2023: Value through Innovation The Boehringer Ingelheim history from 1990 to 2023, with milestones
S&P Animal Health Partnering Oct 2023 S&P Animal Health Partnering Oct 2023 Interview by S&P Global with Megan Grether, discussing Boehringer Ingelheim Animal Health Partnering’s ambition and approach